Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.

Liao X, Gao Y, Liu J, Tao L, Wang D, Xie D, Mo S

DOI: 10.3389/fonc.2021.670798
Published: 2021
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 12/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2021.670798,
  title = {Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.},
  author = {Liao X and Gao Y and Liu J and Tao L and Wang D and Xie D and Mo S},
  year = {2021},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2021.670798},
  url = {https://doi.org/10.3389/fonc.2021.670798}
}

RIS

TY  - JOUR
TI  - Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.
AU  - Liao X
AU  - Gao Y
AU  - Liu J
AU  - Tao L
AU  - Wang D
AU  - Xie D
AU  - Mo S
PY  - 2021
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2021.670798
UR  - https://doi.org/10.3389/fonc.2021.670798
ER  -

APA

X, L., Y, G., J, L., L, T., D, W., D, X., & S, M. (2021). Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.. Frontiers in oncology. https://doi.org/10.3389/fonc.2021.670798

Source records

pubmed · retrieved 2026-09-25T14:03:36.358Z
europe-pmc · retrieved 2026-09-25T14:03:36.369Z
doaj · retrieved 2026-09-25T14:03:36.371Z